Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $95 Price Target
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintains $95 price target.
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintains $95 price target.